Innoviva to Present at the Cowen & Company 36th Annual Health Care Conference 2016

(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/01/16 -- Innoviva, Inc. (NASDAQ: INVA) announced today that Michael W. Aguiar, Innoviva's President and Chief Executive Officer, is scheduled to present at the Cowen & Company 36th Annual Health Care Conference on Tuesday, March 8, 2016 at 10:40 a.m. EST. The conference will be held from March 7-9, 2016 in Boston, MA.

The presentation will be webcast live and can be accessed from Innoviva's website at . Listeners are encouraged to visit the site at least 15 minutes prior to the scheduled presentation to register, download and install any necessary audio software.

Innoviva, formerly known as Theravance, Inc., is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva's website at .

ANORO®, RELVAR®, BREO® and ELLIPTA® are trademarks of the GlaxoSmithKline group of companies.

(INVA-F)



Eric d'Esparbes
Senior Vice President and Chief Financial Officer
650-238-9640

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 01.03.2016 - 21:05 Uhr
Sprache: Deutsch
News-ID 454484
Anzahl Zeichen: 0

contact information:
Town:

SOUTH SAN FRANCISCO, CA

Kategorie:

Drugs

Diese Pressemitteilung wurde bisher 351 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Innoviva to Present at the Cowen & Company 36th Annual Health Care Conference 2016"
steht unter der journalistisch-redaktionellen Verantwortung von

Innoviva, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Innoviva Reports Fourth Quarter and Full Year 2015 Financial Results ...

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/03/16 -- Innoviva, Inc. (NASDAQ: INVA) today reported financial results for the fourth quarter and full year ended December 31, 2015. Net income for the fourth quarter of 2015 was $4.3 million or $0.04 ...

Innoviva to Report Fourth Quarter and Full Year 2015 Financial Results on Februa ...

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/27/16 -- Innoviva, Inc. (NASDAQ: INVA) announced today that it will report financial results for the fourth quarter and full year ended December 31, 2015 after market close on Wednesday, February 3, 201 ...

Theravance, Inc. Announces Name Change to Innoviva, Inc. ...

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/08/16 -- Theravance, Inc. (NASDAQ: THRX), a healthcare-focused asset management company, today announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva� ...

Alle Meldungen von Innoviva, Inc.